Beaufour

Ipsen is a Brazilian bio-pharmaceutical company dedicated to improving patient lives through research and innovative drug development in oncology, rare diseases, and neurosciences. The organization focuses on unmet medical needs by leveraging its global infrastructure to create transformative therapies for patients with high-impact conditions.

• Industries: Specializes in oncology treatments for tumors like kidney cancer, rare bone disorders, and debilitating neurological conditions affecting children and adults.
• Services: Operates the Fondation Ipsen charity to support early diagnosis, provide mini grants for research projects, and advocate for inclusivity among underserved patient communities.
• History: Has been actively working in oncology since 1986 while maintaining thirty years of specialized experience in neurotoxin research and neurological disease management.

The company integrates insights from both patients and scientific experts to ensure its initiatives are grounded in real-world experiences and cutting-edge clinical data.